What is Clairity?
Clairity is at the forefront of leveraging artificial intelligence to revolutionize healthcare. The company's core mission is to enhance the capabilities of healthcare providers, empower patients, and advance the goals of precision medicine. By concentrating on early detection and personalized care, Clairity aims to significantly reduce disparities and improve the accuracy of cancer diagnoses and treatments. Its evidence-based AI solutions are the product of extensive research by leading professionals within prominent medical institutions. Through unlocking critical insights from imaging data, Clairity is dedicated to equipping individuals with the necessary information and choices for their health.
How much funding has Clairity raised?
Clairity has raised a total of $43M across 1 funding round:
Series B
$43M
Series B (2025): $43M with participation from Santé Ventures, Breast Cancer Research Foundation, and ACE
Key Investors in Clairity
Santé Ventures
Santé Ventures is a venture capital firm specializing in innovative healthcare enterprises across Biotech, Medtech, and Healthtech. With over $1 billion in capital, they focus on improving patient health outcomes through strategic investments in emerging technologies and employ proprietary data science software to identify opportunities.
Breast Cancer Research Foundation
The Breast Cancer Research Foundation is a leading not-for-profit organization dedicated to funding clinical and translational research on breast cancer. Since its inception, it has raised substantial capital to support research initiatives at medical institutions globally.
ACE
ACE Company is a multi-stage private equity and venture capital group with a significant asset base, specializing in Secondaries, Buyouts, and Ventures. They provide capital and operational support to disruptive innovators, operating globally with offices in key financial centers.
What's next for Clairity?
The substantial enterprise-level funding and recent strategic investment signal Clairity's readiness to scale its operations and further develop its AI-driven healthcare solutions. This capital infusion is expected to accelerate product development, expand market reach, and potentially forge new strategic partnerships within the healthcare ecosystem. The company's focus on precision medicine and cancer diagnostics positions it for significant impact, and this latest backing will likely fuel advancements in clinical validation and broader adoption of its technology. Clairity appears poised to solidify its position as a key player in the healthtech sector, driving innovation in patient care and diagnostic accuracy.
See full Clairity company page
